A new study published in the New England Journal of Medicine shows that the injection of two monoclonal antibodies—casirivimab and imdevimab—significantly reduces risk of COVID-19 infection among those exposed to the virus. The research…
Moderna published data on the effectiveness of its COVID-19 vaccine, and the news is good: the shot remains 93% effective with two doses administered 6 months post-jab. The immunization is 94% effective 2 weeks following the second dose of…
As the Delta variant rapidly spreads throughout the United States and other wealthy nations, some public health officials and representatives from vaccine manufacturers have suggested that those age 60 and older should receive a COVID-19…
The nonprofit organization, Kaiser Family Foundation (KFF), did some digging to ascertain the prevalence of breakthrough COVID-19 infections in the United States. According to the KFF, the US Centers for Disease Control and Prevention…
Public health officials in Israel have decided to offer a third COVID-19 vaccine as a booster to all fully vaccinated residents age 60 and older over growing concern about the highly contagious Delta variant. The United States has yet to…
An internal report from the United States Centers for Disease Control and Prevention stated that the Delta variant of COVID-19 is just as transmissible as the chicken pox, and is highly likely to cause serious health effects. The report…
A study published in the British Journal of Health Psychology indicates focusing on the vaccine’s efficacy may convince adults who are unsure about receiving the COVID-19 vaccines.